Antithrombotic therapy in the prevention of ischemic stroke / by Richard C. Becker, Frederick A. Spencer.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- text
- computer
- online resource
- 9780199774449
- 0199774447
- Transient ischemic attack -- Chemotherapy
- Transient ischemic attack -- Prevention
- Fibrinolytic agents
- Ischemic Attack, Transient -- drug therapy
- Ischemic Attack, Transient -- prevention & control
- Fibrinolytic Agents
- Accident ischémique transitoire -- Chimiothérapie
- Fibrinolytiques
- HEALTH & FITNESS -- Diseases -- General
- MEDICAL -- Clinical Medicine
- MEDICAL -- Diseases
- MEDICAL -- Evidence-Based Medicine
- MEDICAL -- Internal Medicine
- Fibrinolytic agents
- 616.81061 22
- RC388.5 .B43 2010eb
- WL 355
Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
![]() |
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references.
Print version record.
Cover; Contents; Introduction and Epidemiology; Pathophysiology; Regulatory Factors in Thrombus Formation; Cellular Interactions in Atherothrombosis; Classification of Stroke; Managing Risk Factors for Recurrent Stroke; Antithrombotic Therapy for Prevention of Recurrent TIA and Stroke; Aspirin; Mechanism of Action; Pharmacokinetics; Adverse Effects; Aspirin Administration in Clinical Practice; Secondary Prevention of Vascular Events and Stroke; Aspirin Dosing in Prevention of Recurrent TIA/Stroke; Thienopyridines (Clopidogrel, Ticlopidine, and Prasugrel); Mechanism of Action; Clopidogrel
PharmacokineticsAbsorption; Adverse Effects; Prevention of Vascular Events; Ticlopidine; Prasugrel; Dipyridamole, Extended-Release Dipyridamole/Aspirin Combination (Aggrenox); Mechanism of Action; Pharmacokinetics; Pharmacodynamics; Adverse Effects; Administration in Older Patients; Clinical Experience; Cilostazol; References
Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-rel.
English.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.